Musculoskeletal Flashcards
Osteogenesis imperfecta (OI), (aka brittle bone disease) is a group of hereditary conditions characterized by
abnormal development of type I collagen, a major component of bone matrix but also present in many tissues including skin, joints, and eyes.
Four major variants of this disorder are known and associated with .
variable severity.
Osteogenesis imperfecta
Autosomal dominant (most common) and autosomal recessive forms are seen with
multiple bone fractures being the primary associated pathosis.
Osteogenesis imperfecta
In the severe forms, extreme bone fragility leads to
death in utero or shortly after passage through the birth canal
Osteogenesis imperfecta
. In milder forms, the fractures don’t appear until
childhood (may be confused with child abuse) and don’t shorten life significantly.
Osteogenesis imperfecta
Intermediate forms also are
present.
Osteogenesis imperfecta
Other interesting but inconsistent findings include
blue sclera and opalescent teeth which resemble dentinogenesis imperfecta.
Osteogenesis imperfecta
Management includes
minimizing factors that cause fractures.
Osteogenesis imperfecta
Prognosis depends on the
type of OI and expression of the gene.
Osteopetrosis (marble bone disease) is a group of rare hereditary disorders characterized by
deficient osteoclastic activity with resultant defective bone remodeling.
Osteopetrosis
Both autosomal dominant and autosomal recessive forms are seen with an associated
variable presentation and severity.
Osteopetrosis
Affected patients present with
significantly thickened, heavily mineralized and abnormally brittle bone, prone to fractures.
Osteopetrosis
Since the marrow space is replaced with
dense bone, pancytopenia is common leading to anemia, thrombocytopenia, leukopenia, and an increased prevalence of infections such as osteomyelitis.
Osteopetrosis
Compression on the cranial foramina and nerve roots creates
nerve palsies (blindness, deafness) in many patients.
Osteopetrosis
Because osteoclasts are derived from marrow monocyte precursors, bone marrow transplantation can
provide recipients with fully functional osteoclasts.
Osteopetrosis
May be complicated by .
GVHD
Osteoporosis refers to an increased porosity of the .
skeleton resulting from reduced bone mass with an associated increased bone fragility and increased prevalence of fractures.
Osteoporosis
The process may be
localized (such as cases of disuse in an immobilized extremity) or generalized.
Osteoporosis
Generalized osteoporosis can arise
secondarily to a wide variety of pathoses.
Osteoporosis
When primary, the process most commonly is associated with
aging and is distinctly common in postmenopausal females with associated reduced estrogen (2-3X more frequent).
Osteoporosis
About 25% of women sustain fractures by
age 65 and 50% by age 90.
Osteoporosis
It is the most common form of
acquired, metabolic bone disease (10 million in US, 44 million osteopenia).
Osteoporosis
Osteoporotic fractures affect more women than
heart attack, stroke and breast cancer combined
Osteoporosis
Over 95% of the cases are
primary and appear to be related to reduced estrogen in females and lower androgens in males which develop with age.
Osteoporosis
Because mechanical forces are known to stimulate bone remodeling, reduced physical activity also is associated with
increased bone losses.
Osteoporosis
Other factors thought to be important in osteoporosis are
genetic factors, calcium nutritional state, and secondary causes such as corticosteroid therapy.
Osteoporosis
Bone remodeling occurs throughout life; and normally, there is a balance between
bone resorption and apposition.
Osteoporosis
It appears there is an age-related decrease in
osteoblastic activity as well as an increase in osteoclastic activity.
Osteoporosis
In health, bone formation outpaces resorption until about age
25-30 (time of peak bone mass); followed by a plateau from ages 35-40, with no net gain or loss of bone.
Osteoporosis
After age 40, new bone formation does not quite compensate for
bone loss, resulting in a gradual attrition of bones.
Osteoporosis
A few years prior to and following menopause, the
imbalance worsens; and although the rate of loss slows the bone density continues to decrease.
Osteoporosis
As peak bone mass is generally less in
females, they are typically more vulnerable than men to the impacts of osteopenia/osteoporosis.
Osteoporosis:
Although all bones are affected, those containing abundant cancellous bone such as the spine and femoral head demonstrate the
most severe involvement.
Osteoporosis
The most common complaint is
bone pain, especially backache, secondary to microfractures and collapse.
Common sites of involvement include the vertebral bodies, pelvis, femoral neck, and other weight-bearing bones.
Osteoporosis
Osteoporosis may lead to
kyphoscoliosis and subsequent reduced respiratory function.
Osteoporosis
Fracture often follows
trivial trauma.
Osteoporosis
Hip fractures result in increased
morbidity and mortality.
Pulmonary embolism and pneumoniae are common complications of
Osteoporosis
Pulmonary embolism and pneumoniae are common complications of
fractures, and result in up to 50K deaths annually.
Osteoporosis:
In the early stages,
standard radiographs are not sufficiently sensitive, but the process can be confirmed by a DEXA (dual-energy x-ray absorptiometry) scan.
Osteoporosis:
The primary therapy to slow bone loss includes
adequate dietary calcium intake, vitamin D supplementation, and regular weight-bearing exercise.
Osteoporosis:
This approach works best when initiated prior to age
30 to maximize the peak bone mass.
Osteoporosis:
The first line of medical therapy for affected patients is the use of
bisphosphonates (E.g. Actonel, Boniva, and Fosamax) due to their ability to reduce osteoclastic activity.
Osteoporosis:
Unfortunately, bisphosphonates have been associated with a predisposition to
gnathic osteonecrosis.
Osteoporosis:
Other approaches include
estrogen receptor agonists and several newer hormone based drug therapies (E.g. Forteo, Evista) that do not increase the risk for breast and ovarian cancer.
Osteoporosis:
New treatment modalities also include
monoclonal antibodies such as Denosumab (Prolia) which acts as a Rank-ligand inhibitor.
Paget disease (osteitis deformans) is a fairly common bone disorder characterized by
repetitive episodes of frenzied, regional osteoclastic activity and bone resorption (osteolytic stage), followed by exuberant osteoblastic activity and bone formation (mixed osteoclastic-osteoblastic stage), and finally by an apparent exhaustion of cellular activity (osteosclerotic stage).
Paget disease
The net effect is a gain in
bone mass; but the newly formed dense bone is disordered, structurally weak and prone to fracture.
Paget disease
These processes produce
skeletal deformation caused by accumulation of excessive amounts of abnormal, unstable bone.
Paget disease
The abnormality is rare before the age of
40 and exhibits a slightly increased prevalence in males.
Paget disease
There is a marked variation in prevalence in different populations with the pathosis being
rare in individuals from China, Japan, and Africa while affecting up to 10% of the white adult population in many western countries.
Paget disease
The lesions may be confined to a
single bone (monostotic, represent ~15%), involve numerous bones (polyostotic, represents ~85%) or rarely the entire skeleton.
Paget disease
The etiology is unknown, but
paramyxovirus is suspected.
Paget disease
As mentioned, the process evolves through
three stages.
Paget disease
Initially, there is a period of
osteoclastic activity, hypervascularity and bone loss that is followed by a phase of mixed osteoclastic and osteoblastic proliferation which gradually evolves into a late osteosclerotic phase.
Paget disease
The typical microscopic features of the disease show
active osteoclastic and osteoblastic activity, many times on the same trabecula of bone.
Paget disease
The interstitial tissue is
loosely arranged and highly vascular.
Paget disease
The histopathologic features form a
mosaic pattern of bone.
Paget disease
Radiographically, the bone shows a mixture of
radiolucent-radiopaque areas referred to as a cotton-wool pattern.
Paget disease:
Any bone may be affected. About 80-90% are
asymptomatic, and most are discovered on routine radiographs or blood studies. =
Paget disease:
When present, the clinical manifestations and symptoms are
variable and include bone enlargement, bone pain, deformity, cranial nerve compression, hearing loss and visual disturbances, bowing of bones and fractures.
Paget disease:
Other possible complications include
leontiasis ossea (lion face, characterized by an overgrowth of the facial and cranial bones) and a slight increased risk (1 % lifetime) for development of sarcomas (particularly osteosarcoma).
Paget disease:
The diagnosis is made
secondary to the radiographic and microscopic appearances combined with demonstration of elevated levels of urinary hydroxyproline (⇑bone resorption) and serum alkaline phosphatase (⇑bone apposition).
Paget disease:
Most patients have
mild symptoms which can be controlled by calcitonin or bisphosphonates and analgesics.
Hyperparathyroidism is characterized by
inappropriate secretion of PTH (parathyroid hormone).
Hyperparathyroidism
PTH plays a central role in
calcium homeostasis via its effects on: osteoclast activation, increased calcium resorption by the kidneys, and increased synthesis of vitamin D (kidneys) resulting in increased calcium absorption from the gut.
Hyperparathyroidism
The net result is an elevation in
serum calcium.
Hyperparathyroidism
Patients often develop
skeletal changes (bone appears ground glass and osteoporotic) due to activation of osteoclasts.
Hyperparathyroidism
Osteitis Fibrosa Cystica (cyst-like brown tumors of bone) can also be observed in patients with
hyperparathyroidism. These lesions are histopathologically identical to central giant cell granuloma of the jaws.